Coglapix
Active substance
ATC code
Species
Pigs.
Indications
For the active immunisation of pigs as an aid to control pleuropneumonia caused by Actinobacillus pleuropneumoniae serotypes 1 and 2, by reducing the clinical signs and lung lesions associated with the disease.
Onset of immunity: 21 days following second vaccination
Duration of immunity: 16 weeks following second vaccination
Dose to be administered and administration route
Intramuscular use.
The preferred site of administration is the neck region.
Vaccination schedule: 2 doses administered to animals from 7 weeks of age with an interval of 3 weeks between doses.
Shake well before use.
Use sterile syringe and needle, respect aseptic conditions of vaccination.
Adverse reactions
Pigs
|
Very common (>1 animal / 10 animals treated): |
Injection site swelling1 |
|
Common (1 to 10 animals / 100 animals treated): |
Elevated temperature2 |
|
Uncommon (1 to 10 animals / 1000 animals treated |
Prostration3 |
|
Very rare (<1 animal / 10000 animals treated) |
Anaphylactic type reaction4 |
1 of maximum 2x3.2 cm persisting for at least 8 days
2 Up to 1.8 °C for 2 hours on days 1 or 2 after vaccination.
3 For a view hours after vaccination.
4 Appropriate symptomatic treatment recommended.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Dispensing
POM-V - Prescription Only Medicine – Veterinarian
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 15052/5077 |
| EAN | 3411112111206 |
